Hemophilia Stocks List

Hemophilia Stocks Recent News

Date Stock Title
Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
Nov 20 PFE Pfizer names head of oncology as new R&D chief
Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
Nov 20 PFE Pfizer Names New R&D Chief
Nov 20 PFE Pfizer, under pressure to change, names oncology head as new R&D chief
Nov 20 PFE Is It Time to Sell Eli Lilly and Pfizer Stocks?
Nov 20 PFE European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
Nov 20 PFE Flagship, Pfizer alliance yields two more startup deals
Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
Nov 19 PFE Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules
Nov 19 SGMO Sangamo stock climbs 12% post-market on FDA update for ST-503
Nov 19 SGMO Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
Nov 19 BAX Baxter to Present at 7th Annual Evercore HealthCONx Conference
Nov 19 PFE BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
Hemophilia

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding longer after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or a decreased level of consciousness.There are two main types of haemophilia: haemophilia A, which occurs due to not enough clotting factor VIII, and haemophilia B, which occurs due to not enough clotting factor IX. They are typically inherited from one's parents through an X chromosome with a nonfunctional gene. Rarely a new mutation may occur during early development or haemophilia may develop later in life due to antibodies forming against a clotting factor. Other types include haemophilia C, which occurs due to not enough factor XI, and parahaemophilia, which occurs due to not enough factor V. Acquired haemophilia is associated with cancers, autoimmune disorders, and pregnancy. Diagnosis is by testing the blood for its ability to clot and its levels of clotting factors.Prevention may occur by removing an egg, fertilizing it, and testing the embryo before transferring it to the uterus. Treatment is by replacing the missing blood clotting factors. This may be done on a regular basis or during bleeding episodes. Replacement may take place at home or in hospital. The clotting factors are made either from human blood or by recombinant methods. Up to 20% of people develop antibodies to the clotting factors which makes treatment more difficult. The medication desmopressin may be used in those with mild haemophilia A. Studies of gene therapy are in early human trials.Haemophilia A affects about 1 in 5,000–10,000, while haemophilia B affects about 1 in 40,000, males at birth. As haemophilia A and B are both X-linked recessive disorders, females are rarely severely affected. Some females with a nonfunctional gene on one of the X chromosomes may be mildly symptomatic. Haemophilia C occurs equally in both sexes and is mostly found in Ashkenazi Jews. In the 1800s haemophilia was common within the royal families of Europe. The difference between haemophilia A and B was determined in 1952. The word is from the Greek haima αἷμα meaning blood and philia φιλία meaning love.

Browse All Tags